Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Richard S Garfein"'
Autor:
Leo Beletsky, Richard S. Garfein, Steffanie A. Strathdee, Maria Luisa Mittal, Mario Morales, Eileen V. Pitpitan, Teresita Rocha-Jimenez, Eyal Oren, Javier A. Cepeda, Erika Clairgue, Annick Borquez, Pieter Baker, Jaime Arredondo
Publikováno v:
Harm Reduction Journal, Vol 18, Iss 1, Pp 1-10 (2021)
Harm reduction journal, vol 18, iss 1
Harm Reduction Journal
Harm reduction journal, vol 18, iss 1
Harm Reduction Journal
Background Police constitute a structural determinant of health and HIV risk of people who inject drugs (PWID), and negative encounters with law enforcement present significant barriers to PWID access to harm reduction services. Conversely, police ma
Autor:
Krishna K. Bommakanti, Laramie L. Smith, Lin Liu, Diana Do, Jazmine Cuevas-Mota, Kelly Collins, Fatima Munoz, Timothy C. Rodwell, Richard S. Garfein
Publikováno v:
BMC Public Health, Vol 20, Iss 1, Pp 1-9 (2020)
Abstract Background Mobile health (mHealth) interventions have the potential to improve health through patient education and provider engagement while increasing efficiency and lowering costs. This raises the question of whether disparities in access
Externí odkaz:
https://doaj.org/article/1c38a29eea1143f6af55d990166e235b
Autor:
Lorena S. Pacheco, David A. Hernández-Ontiveros, Esmeralda Iniguez-Stevens, Stephanie Brodine, Richard S. Garfein, Margarita Santibañez, Miguel A. Fraga
Publikováno v:
BMC Public Health, Vol 18, Iss 1, Pp 1-11 (2018)
Abstract Background Diabetes is a leading cause of morbidity and mortality in Mexico and understudied among indigenous populations. This study aimed to determine the prevalence and identify correlates of Type 2 diabetes mellitus (Type 2 DM) and metab
Externí odkaz:
https://doaj.org/article/7ac6d937e5194114a438ffdedb1e14b9
Autor:
Stephanie A. Meyers, Ayden Scheim, Sonia Jain, Xiaoying Sun, M. J. Milloy, Kora DeBeck, Kanna Hayashi, Richard S. Garfein, Dan Werb
Publikováno v:
Harm Reduction Journal, Vol 15, Iss 1, Pp 1-5 (2018)
Abstract Aim Individuals experience differential risks in their initiation into drug injecting based on their gender. Data suggest women are more likely to be injected after their initiator and to share injection equipment. Little is known, however,
Externí odkaz:
https://doaj.org/article/42b4cc7eeaf6452dbf4bc1235925a92d
Autor:
Erik J. Groessl, Theodore G. Ganiats, Naomi Hillery, Andre Trollip, Roberta L. Jackson, Donald G. Catanzaro, Timothy C. Rodwell, Richard S. Garfein, Camilla Rodrigues, Valeriu Crudu, Thomas C. Victor, Antonino Catanzaro
Publikováno v:
BMC Infectious Diseases, Vol 18, Iss 1, Pp 1-10 (2018)
Abstract Background Growth-based drug susceptibility testing (DST) is the reference standard for diagnosing drug-resistant tuberculosis (TB), but standard time to result (TTR) is typically ≥ 3 weeks. Rapid tests can reduce that TTR to days or hours
Externí odkaz:
https://doaj.org/article/e7150ab753a942d9977028068c9040ce